Risk for Second Primary Ovarian Cancer: A Large Population Based on Surveillance, Epidemiology, and End Results Database

被引:0
|
作者
Hu, Haiyang [1 ]
Ren, Yangsheng [1 ]
Li, Huixing [1 ]
Zhang, Tishuo [1 ]
Sun, Lin [1 ]
机构
[1] Jining Med Univ, Affiliated Hosp, Dept Gynecol, Jining, Peoples R China
关键词
Second primary ovarian cancer; Standardized incidence ratios; First primary cancer types; Diagnosis interval; Radiotherapy; BREAST-CANCER; PRIMARY MALIGNANCIES; WOMEN; ASSOCIATION;
D O I
10.1159/000542044
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: This study aims to evaluate the likelihood of developing a second primary ovarian cancer (OC) considering factors including age, race, and the types of initial malignancies encountered. Methods: This study employed a retrospective cohort approach, compiling data on individuals diagnosed with OC from the Surveillance, Epidemiology, and End Results (SEER) program databases spanning the years 1975-2019. The analysis used standardized incidence ratios (SIRs) with 95% confidence intervals (CIs) to determine the likelihood of developing OC. The result was further refined by categorizing the data based on patient age, race background, first primary cancer types, the time elapsed since the second primary cancer diagnosis, and radiotherapy treatment. Results: A total of 1,536,151 patients with second primary cancer being OC were included. The SIR of the second primary OC was observed to be elevated among patients between the ages of 18-64 years (SIR: 1.09, 95% CI: 1.06-1.13). In contrast, for patients who were 65 years of age or older, the SIR for a second primary OC was found to be relatively lower (SIR: 0.87, 95% CI: 0.83-0.91). A lowering, however, not statistically significant, of the SIR of the second primary OC in patients with white race was presented. Within 2 months to 1-year diagnosis interval, the SIR of the second primary OC was highest (SIR: 1.48, 95% CI: 1.37-1.61). Liver, gallbladder, intrahepatic, and other bile ducts (SIR: 2.00, 95% CI: 1.38-2.81), and breast cancer (SIR: 1.20, 95% CI: 1.15-1.25) had higher SIRs of second primary OC. Conclusion: This study identifies age, ethnicity, the time span between the diagnoses, and the types of initial cancers as factors correlated with the occurrence of a second primary OC. Our findings suggest that targeted surveillance should be considered for high-risk groups. (c) 2024 S. Karger AG, Basel
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data
    Thakur, Manish K.
    Ruterbusch, Julie J.
    Schwartz, Ann G.
    Gadgeel, Shirish M.
    Beebe-Dimmer, Jennifer L.
    Wozniak, Antoinette J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (01) : 46 - 53
  • [22] Risk prediction of second primary malignancies after gynecological malignant neoplasms resection with and without radiation therapy: a population-based surveillance, epidemiology, and end results (SEER) analysis
    Wang, Jing
    Zhang, Chan
    Xiang, Yaoxian
    Han, Baojuan
    Cheng, Yurong
    Tong, Yingying
    Yan, Dong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (14) : 12703 - 12711
  • [23] Breast cancer in thyroid cancer survivors: An analysis of the Surveillance, Epidemiology, and End Results-9 database
    Kuo, Jennifer H.
    Chabot, John A.
    Lee, James A.
    SURGERY, 2016, 159 (01) : 23 - 29
  • [24] Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer A Retrospective Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database
    Chau, Bonny
    Loggers, Elizabeth T.
    Cranmer, Lee D.
    Mogal, Harveshp
    Sharib, Jeremy M.
    Kim, Edward Y.
    Schaub, Stephanie K.
    Paulson, Kelly G.
    Linden, Hannah M.
    Specht, Jennifer M.
    Kim, Janice N.
    Javid, Sara H.
    Wagner, Michael J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (12): : 567 - 571
  • [25] Prevalence of breast cancer in ovarian cancer patients and its impact on patient survival: An analysis of the surveillance, epidemiology, and end results data
    Zhang, Ni
    Zhang, Wanfang
    Liu, Yu
    Qiu, Hui
    Wu, Qiuji
    TUMORI JOURNAL, 2025, 111 (02): : 164 - 173
  • [26] Breast Reconstruction Does Not Affect the Survival of Patients with Breast Cancer Located in the Central and Nipple Portion: A Surveillance, Epidemiology, and End Results Database Analysis
    Xiong, Mingchen
    Liu, Zeming
    Lv, Wenchang
    Zhao, Chongru
    Wang, Yichen
    Tan, Yufang
    Zhang, Qi
    Wu, Yiping
    Zeng, Hong
    FRONTIERS IN SURGERY, 2022, 9
  • [27] The effect of marital status on endometrial cancer-related diagnosis and prognosis: a Surveillance Epidemiology and End Results database analysis
    Dong, Jia
    Dai, Qinjin
    Zhang, Fan
    FUTURE ONCOLOGY, 2019, 15 (34) : 3963 - 3976
  • [28] Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis
    Nantavithya, Chonnipa
    Paulino, Arnold C.
    Liao, Kaiping
    McGovern, Susan L.
    Grosshans, David R.
    McAleer, Mary F.
    Woodhouse, Kristina D.
    Khatua, Soumen
    Chintagumpala, Murali M.
    Majd, Nazanin K.
    Yeboa, Debra N.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (08)
  • [29] Treatment of Esophageal Cancer Based on Histology A Surveillance Epidemiology and End Results Analysis
    Chang, Daniel T.
    Chapman, Christopher
    Shen, John
    Su, Zheng
    Koong, Albert C.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (04): : 405 - 410
  • [30] Determining breast cancer axillary surgery within the surveillance epidemiology and end results-Medicare database
    Schmocker, Ryan K.
    Caretta-Weyer, Holly
    Weiss, Jennifer M.
    Ronk, Katie
    Havlena, Jeffrey
    Loconte, Noelle K.
    Decker, Marquita
    Smith, Maureen A.
    Greenberg, Caprice C.
    Neuman, Heather B.
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (08) : 756 - 759